查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301116

被忽视的热带疾病诊断市场规模、份额和趋势分析报告：按疾病、诊断方法、服务类型、最终用途、细分市场趋势：2023-2030

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End Use, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10个工作天内

价格

被忽视的热带病诊断市场增长和趋势

根据 GrandView Research, Inc. 的最新报告，到 2030 年，全球被忽视的热带病诊断市场将达到 89.7 亿美元，预测期内復合年增长率为 4.5%。预计将扩大。

疾病负担的增加、疾病早期检测需求的增加以及技术的互补进步预计将推动需求增长。

人们对被忽视的热带病及其对经济和人口影响的兴趣日益浓厚，推动了对早期疾病检测方法开发的需求。 这种日益增长的关注反映在一系列旨在对抗被忽视热带病的计划的启动上。 例如，被忽视的热带病全球网络致力于提高人们的认识并提供资金，这对于消除最常见的被忽视的热带疾病至关重要。 此外，多家公司正在努力开发更复杂、更便宜的热带病诊断方法。 2021年1月，诺华公司与世界卫生组织签署了全球控制麻风病的协议。 预计这将在预测期内支持该市场的增长。

根据世界卫生组织的数据，截至 2022 年 1 月，全球有超过 15 亿人患有土源性蠕虫感染。 Kato-Katz 方法是 WHO 的黄金标准，广泛用于诊断 STH 的严重程度。 这些传染病广泛分布于热带和亚热带地区，在美国、撒哈拉以南非洲、东亚和中国频繁发生。 此外，主要参与者的存在预计将推动整个市场的增长。 这些参与者参与新产品开发被认为有助于 NTD 诊断市场的发展。

被忽视的热带病诊断市场报告亮点

  • 从疾病类型来看，由于患病率不断上升以及诊断测试的广泛采用，土源性蠕虫病将在 2022 年占据市场主导地位。
  • 由于分子诊断技术的研发以及对即时护理产品的需求增加，2022 年的市场将由分子/高级诊断领域主导
  • 就 2022 年的市场份额而言，由于测试数量较多以及基础设施和人力方面的广泛辅助支持，集中式服务占据最大部分。
  • 从最终用途来看，由于 POCT 服务越来越受欢迎和需求不断增加，家庭医疗保健预计将成为增长最快的领域
  • 由于被忽视的热带疾病负担沉重、医疗保健支出不断增加、技术进步迅速，以及客户对使用 PCR 检测诊断被忽视热带疾病的意识不断增强，亚太地区将在 2022 年主导全球市场。
  • 由于 IVD 产品的渗透率不断提高以及新兴国家 NTD 的高疾病负担，预计拉丁美洲未来将出现显着增长。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 市场定义
    • 信息分析
    • 市场形成和数据可视化
    • 验证和发布数据
  • 调查先决条件
  • 信息获取
    • 初步调查
  • 信息或数据分析
  • 市场形成和验证
  • 市场模式
  • 全球市场：计算复合年增长率
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第三章市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/辅助市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 行业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 感染的影响分析

第四章疾病业务分析

  • 被忽视的热带病诊断市场：疾病波动分析
  • 登革热
  • 基孔肯雅热
  • 狂犬病
  • 麻风病
  • 布鲁里溃疡
  • 余泽
  • 淋巴丝虫病
  • 绦虫病/囊尾蚴病
  • 食物中毒吸虫感染
  • 包虫病
  • 恰加斯病
  • 麦地那龙线虫病
  • 人类非洲锥虫病（昏睡病）
  • 土源性蠕虫病
  • 盘尾丝虫病
  • 血吸虫病
  • 疥疮和其他生态寄生虫
  • 蛇咬伤毒液
  • 利甚曼病

第五章诊断方法的业务分析

  • 被忽视的热带病诊断市场：诊断方法的变异分析
  • 传统方法
  • 分子/现代方法

第六章服务类型业务分析

  • 被忽视的热带病诊断市场：服务类型的变化分析
  • 集中服务
  • POC 服务

第 7 章：最终用途业务分析

  • 被忽视的热带病诊断市场：最终用途变异分析
  • 临床实验室
    • 实验室检测市场，2018-2030
    • 医院和诊所
    • 家庭医疗保健

第 8 章区域业务分析

  • 2022 年和 2030 年被忽视的热带病诊断市场份额（按地区）
  • 北美
    • SWOT分析
    • 北美被忽视的热带病诊断市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 欧洲被忽视的热带病诊断市场，2018-2030
    • 英国
    • 德国
  • 亚太地区
    • SWOT分析
    • 2018-2030 年亚太地区被忽视的热带病诊断市场
    • 中国
    • 印度
    • 印度尼西亚
    • 马来西亚
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲被忽视的热带病诊断市场，2018-2030 年
    • 巴西
    • 哥伦比亚
    • 委内瑞拉
  • MEA
    • SWOT分析
    • MEA 被忽视的热带病诊断市场，2018-2030 年
    • 尼日利亚

第 9 章竞争格局

  • 公司分类
  • 战略规划
  • 2022 年公司市场份额分析
  • 公司简介/列表
    • F. Hoffmann-La Roche Ltd
    • Abbott
    • Thermo Fisher Scientific Inc.
    • ZeptoMetrix, LLC
    • InBios International, Inc.
    • Genome Diagnostics Pvt. Ltd.
    • Omega Diagnostics Group PLC
    • Coris BioConcept
    • DiaSys Diagnostic Systems GmbH
    • GmbH Oscar Medicare Pvt Ltd.
Product Code: GVR-2-68038-319-5

Neglected Tropical Diseases Diagnosis Market Growth & Trends

The global neglected tropical diseases diagnosis market size is expected to reach USD 8.97 billion by 2030, expanding at a CAGR of 4.5% during the forecast period, according to a new report by Grand View Research, Inc. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Increasing concern regarding neglected tropical diseases and their impact on the population as well as economies has boosted the demand for the development of early disease detection methods. This growth in concern is evident in the launch of a substantial number of programs aiming to combat NTDs. For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. In January 2021, Novartis AG signed an agreement with the WHO to manage leprosy across the globe. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

According to the WHO, as of January 2022, more than 1.5 billion people are infected with soil-transmitted helminth infections worldwide. The Kato-Katz technique is the WHO gold standard that is widely used to diagnose the intensity of STHs. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China. Furthermore, the presence of key players is expected to fuel the overall market growth. The involvement of these players in new product development is considered to be the contributing factor to the development of the NTD diagnosis market.

Neglected Tropical Disease Diagnosis Market Report Highlights

  • By disease type, the soil-transmitted helminthiases dominated the market in 2022, owing to the increasing prevalence and high adoption of diagnostics tests
  • The molecular/modern diagnostic segment dominated the market in 2022, owing to an increase in R&D for molecular diagnostic techniques coupled with a rise in demand for point-of-care products
  • Centralized service accounted for the largest segment in terms of market share in 2022 due to high procedure volume and the wide presence of ancillary support in terms of infrastructure and manpower
  • By end-use, home healthcare is expected to be the fastest-growing segment as a result of the growing popularity and demand for POCT services
  • Asia Pacific dominated the global market in 2022, owing to the high disease burden of NTDs, increased healthcare expenditure, rapid technological advancements, and a rise in customer awareness about the use of PCR tests in diagnosing NTDs
  • Latin America is expected to grow considerably in the future, owing to increased IVD product penetration and the high disease burden of NTDs in developing countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objective
    • 1.9.1. Objective 1
    • 1.9.2. Objective2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of neglected tropical diseases
      • 3.2.1.2. Growing investments and governmental funding in the development of diagnostics
      • 3.2.1.3. Growing awareness of neglected tropical diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Shift of funds to tackle other diseases in low health budgets
      • 3.2.2.2. Shortage of funding from international partners and foreign government
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Disease Business Analysis

  • 4.1. Neglected Tropical Disease Diagnosis Market: Disease Movement Analysis
  • 4.2. Dengue
    • 4.2.1. Dengue Market, 2018 - 2030 (USD Million)
  • 4.3. Chikungunya
    • 4.3.1. Chikungunya Market, 2018 - 2030 (USD Million)
  • 4.4. Rabies
    • 4.4.1. Rabies Market, 2018 - 2030 (USD Million)
  • 4.5. Leprosy
    • 4.5.1. Leprosy Market, 2018 - 2030 (USD Million)
  • 4.6. Buruli Ulcer
    • 4.6.1. Buruli Ulcer Market, 2018 - 2030 (USD Million)
  • 4.7. Yaws
    • 4.7.1. Yaws Market, 2018 - 2030 (USD Million)
  • 4.8. Lymphatic Filariasis
    • 4.8.1. Lymphatic Filariasis Market, 2018 - 2030 (USD Million)
  • 4.9. Taeniasis/Cysticercosis
    • 4.9.1. Taeniasis/Cysticercosis Market, 2018 - 2030 (USD Million)
  • 4.10. Foodborne Trematode Infections
    • 4.10.1. Foodborne Trematode Infections Market, 2018 - 2030 (USD Million)
  • 4.11. Echinococcosis
    • 4.11.1. Echinococcosis Market, 2018 - 2030 (USD Million)
  • 4.12. Chagas Disease
    • 4.12.1. Chagas Disease Market, 2018 - 2030 (USD Million)
  • 4.13. Dracunculiasis
    • 4.13.1. Dracunculiasis Market, 2018 - 2030 (USD Million)
  • 4.14. Human African Trypanosomiasis (Sleeping Sickness)
    • 4.14.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2018 - 2030 (USD Million)
  • 4.15. Soil-Transmitted Helminthiases
    • 4.15.1. Soil-Transmitted Helminthiases Market, 2018 - 2030 (USD Million)
  • 4.16. Onchocerciasis
    • 4.16.1. Onchocerciasis Market, 2018 - 2030 (USD Million)
  • 4.17. Schistosomiasis
    • 4.17.1. Schistosomiasis Market, 2018 - 2030 (USD Million)
  • 4.18. Scabies and Other Ecoparasites
    • 4.18.1. Scabies and Other Ecoparasites Market, 2018 - 2030 (USD Million)
  • 4.19. Snakebite Envenoming
    • 4.19.1. Snakebite Envenoming Market, 2018 - 2030 (USD Million)
  • 4.20. Leishmaniases
    • 4.20.1. Leishmaniases Market, 2018 - 2030 (USD Million)

Chapter 5. Diagnostic Method Business Analysis

  • 5.1. Neglected Tropical Disease Diagnosis Market: Diagnostic Method Movement Analysis
  • 5.2. Conventional Method
    • 5.2.1. Conventional Method Market, 2018 - 2030 (USD Million)
  • 5.3. Molecular/Modern Method
    • 5.3.1. Molecular/Modern Method Market, 2018 - 2030 (USD Million)

Chapter 6. Service Type Business Analysis

  • 6.1. Neglected Tropical Disease Diagnosis Market: Service Type Movement Analysis
  • 6.2. Centralized Service
    • 6.2.1. Centralized Service Market, 2018 - 2030 (USD Million)
  • 6.3. POC Service
    • 6.3.1. POC Service Market, 2018 - 2030 (USD Million)

Chapter 7. End-Use Business Analysis

  • 7.1. Neglected Tropical Disease Diagnosis Market: End-Use Movement Analysis
  • 7.2. Clinical Labs
    • 7.2.1. Clinical Labs Market, 2018 - 2030 (USD Million)
    • 7.2.2. Hospital/Clinics
      • 7.2.2.1. Hospital/Clinics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Home Healthcare
      • 7.2.3.1. Home Healthcare Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Neglected Tropical Disease Diagnosis Market Share By Region, 2022 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. U.S. Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Canada Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. UK Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Germany Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. China Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. India Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.5. Indonesia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Indonesia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.4.6. Malaysia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Malaysia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Brazil Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.4. Colombia
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Colombia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.5.5. Venezuela
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. Venezuela Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
    • 8.6.3. Nigeria
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Nigeria Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Abbott
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Thermo Fisher Scientific Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. ZeptoMetrix, LLC
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. InBios International, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Genome Diagnostics Pvt. Ltd.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Omega Diagnostics Group PLC
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Coris BioConcept
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. DiaSys Diagnostic Systems GmbH
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. GmbH Oscar Medicare Pvt Ltd.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Neglected Tropical Diseases Diagnosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 5 Global Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 6 Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 7 Global Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 8 North America Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 10 North America Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 11 North America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 12 North America Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 14 U.S. Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 15 U.S. Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 18 Canada Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 19 Canada Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 20 Canada Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 21 Europe Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 23 Europe Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 24 Europe Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 25 Europe Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 26 UK Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 27 UK Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 28 UK Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 29 UK Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 31 Germany Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 32 Germany Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 33 Germany Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 39 China Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 40 China Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 41 China Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 42 China Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 43 India Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 44 India Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 45 India Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 46 India Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 47 Indonesia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 48 Indonesia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 49 Indonesia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 50 Indonesia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 51 Malaysia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 52 Malaysia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 53 Malaysia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 54 Malaysia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 55 Latin America Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 56 Latin America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 57 Latin America Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 58 Latin America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 59 Latin America Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 60 Brazil Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 61 Brazil Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 62 Brazil Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 63 Brazil Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 64 Colombia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 65 Colombia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 66 Colombia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 67 Colombia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 68 Venezuela Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 69 Venezuela Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 70 Venezuela Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 71 Venezuela Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 77 Nigeria Neglected Tropical Diseases Diagnosis Market, By Disease, 2018 - 2030 (USD Million)
  • Table 78 Nigeria Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018 - 2030 (USD Million)
  • Table 79 Nigeria Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 80 Nigeria Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Neglected Tropical Diseases Diagnosis Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Neglected tropical diseases diagnosis market: Disease outlook and key takeaways
  • Fig. 15 Neglected tropical diseases diagnosis market: Disease movement analysis & market share 2022 & 2030
  • Fig. 16 Dengue neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 17 Chikungunya neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 18 Rabies market, 2018 - 2030 (USD Million)
  • Fig. 19 Leprosy neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 20 Buruli ulcer neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 21 Yaws market, 2018 - 2030 (USD Million)
  • Fig. 22 Lymphatic filariasis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 23 Taeniasis/Cysticercosis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 24 Foodborne trematode infections market, 2018 - 2030 (USD Million)
  • Fig. 25 Echinococcosis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 26 Chagas disease neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 27 Dracunculiasis market, 2018 - 2030 (USD Million)
  • Fig. 28 Human African trypanosomiasis (sleeping sickness) neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 29 Soil-transmitted helminthiases neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 30 Onchocerciasis market, 2018 - 2030 (USD Million)
  • Fig. 31 Schistosomiasis neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 32 Scabies and other ecoparasites neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 33 Snakebite envenoming market, 2018 - 2030 (USD Million)
  • Fig. 34 Leishmaniases market, 2018 - 2030 (USD Million)
  • Fig. 35 Neglected tropical diseases diagnosis market: Diagnostic method outlook and key takeaways
  • Fig. 36 Neglected tropical diseases diagnosis market: Diagnostic method movement analysis & market share 2022 & 2030
  • Fig. 37 Conventional method market, 2018 - 2030 (USD Million)
  • Fig. 38 Molecular/Modern method market, 2018 - 2030 (USD Million)
  • Fig. 39 Neglected tropical diseases diagnosis market: Service type outlook and key takeaways
  • Fig. 40 Neglected tropical diseases diagnosis market: Service type movement analysis & market share 2022 & 2030
  • Fig. 41 Centralized service neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 42 POC service neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 43 Neglected tropical diseases diagnosis market: End-Use outlook and key takeaways
  • Fig. 44 Neglected tropical diseases diagnosis market: End-Use movement analysis & market share 2022 & 2030
  • Fig. 45 Clinical labs neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 46 Hospitals/Clinics neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 47 Home healthcare neglected tropical diseases diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 48 Regional Marketplace: Key Takeaways
  • Fig. 49 Regional Outlook, 2022 & 2030
  • Fig. 50 Regional Market Dashboard
  • Fig. 51 Regional Market Place: Key Takeaways
  • Fig. 52 North America, SWOT Analysis
  • Fig. 53 Europe, SWOT Analysis
  • Fig. 54 Asia Pacific, SWOT Analysis
  • Fig. 55 Latin America, SWOT Analysis
  • Fig. 56 MEA, SWOT Analysis
  • Fig. 57 North America
  • Fig. 58 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 U.S.
  • Fig. 60 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Canada
  • Fig. 62 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Europe
  • Fig. 64 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 UK
  • Fig. 66 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Germany
  • Fig. 68 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 China
  • Fig. 72 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 India
  • Fig. 74 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Indonesia
  • Fig. 76 Indonesia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Malaysia
  • Fig. 78 Malaysia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America
  • Fig. 80 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil
  • Fig. 82 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Colombia
  • Fig. 84 Colombia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 MEA
  • Fig. 86 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Nigeria
  • Fig. 88 Nigeria Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Strategy Mapping